Aurobindo Pharma (BOM:524804) Institutional Ownership: 29.02% (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524804 Aurobindo Pharma Ltd BOM:524804
82 GF Score
Price ₹1,735.00
GF Value ₹1,420.96
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aurobindo Pharma Institutional Ownership?

Aurobindo Pharma BOM:524804 +3.03% 82 Institutional Ownership is 29.02% as of Sep. 20, 2026. GuruFocus rates BOM:524804 with a GF Score™ of 82/100 and a GF Value™ of ₹1,420.96 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aurobindo Pharma's institutional ownership is 29.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aurobindo Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aurobindo Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Aurobindo Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Aurobindo Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurobindo Pharma Institutional Ownership Chart

Aurobindo Pharma Historical Data

The historical data trend for Aurobindo Pharma can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 30.63 30.09 30.60 29.72 29.35 29.28 29.41 28.96 28.86 29.02
BOM:524804
82GF Score
Aurobindo Pharma Ltd BOM:524804
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurobindo Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 29.02% mean?
Aurobindo Pharma (BOM:524804) has a Institutional Ownership of 29.02% as of Sep. 20, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aurobindo Pharma and its competitors.
Is Aurobindo Pharma's Institutional Ownership too high?
Aurobindo Pharma's current Institutional Ownership is 29.02%. Overall, Aurobindo Pharma has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aurobindo Pharma's Institutional Ownership compare to ZTS?
Aurobindo Pharma's Institutional Ownership of 29.02% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aurobindo Pharma and its competitors. Aurobindo Pharma's current Institutional Ownership is 29.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurobindo Pharma stock overvalued right now?
Based on GuruFocus' analysis, Aurobindo Pharma (BOM:524804) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,420.96, compared to a current price of ₹1,735.00 — trading 22.1% above its estimated fair value. The current Institutional Ownership is 29.02%. Aurobindo Pharma's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Aurobindo Pharma (BOM:524804), the current Institutional Ownership is 29.02% as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurobindo Pharma (BOM:524804) Overvalued in 2026?

Based on GuruFocus' analysis, Aurobindo Pharma stock appears to be overvalued. The current stock price of ₹1,735.00 is trading 22.1% above its estimated GF Value™ of ₹1,420.96. GuruFocus considers Aurobindo Pharma to be Modestly Overvalued.

Key valuation signals for BOM:524804:

  • Institutional Ownership: 29.02%
  • GF Value™: ₹1,420.96 vs. price of ₹1,735.00 (22.1% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the BOM:524804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurobindo Pharma Business Description

Other Exchanges AUROPHARMA:India
Address Plot No. 1, Survey No. 83/1, Galaxy, Floors 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500032
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.
82GF Score

Get the complete analysis for BOM:524804

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,735.00
Price
₹1,420.96
GF Value